bosutinib
Pfizer
['leukemia', 'myeloid', 'pfizer']
see an analysis of a phase 3 trial investigating the efficacy and safety of tkis after 5 years follow-up in us patients with newly diagnosed chronic phase #chronicmyeloidleukemia at #ash22 3026 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ